In summary, our study demonstrates that CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt signaling activity and reveals a molecular mechanism by which CDX2 regulates the transcriptional activation of GSK-3β and Axin2. This evidence concerns the gene CDX2 and colonic neoplasm.